Tags: Medical Groupsmedical-practiceConsumer / Employer, Daily, Legal, SYN, Top Storyabortionpublic health
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Three States Renew Effort to Reduce Access to Abortion Pill Mifepristone - about 1 month ago | |
2 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | SMC recommends Yselty for treating uterine fibroids - 13 days ago | |
3 | Rachael Robertson MedPage Today Investigations & enterprise writer. Covers ob/gyn. @medpagetoday. NYC via PGH | FDA OKs First Orally Dissolving Birth Control Pill - 4 months ago Publisher Retracts Three Abortion Studies - 10 months ago FDA Clears First At-Home Kit for Artificial Insemination - 12 months ago Misoprostol Alone in Self-Managed Abortion Is Highly Effective - about 1 year ago | |
4 | David Nield Science Alert Freelance tech, science writer. Marple, Manchester, UK | ||
5 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
6 | Li Zhou Vox Politics reporter @voxdotcom.
Previously tech policy. Washington, DC | ||
7 | Sarah Owermohle STAT News Health reporter @STATNews. Covers Biden's agenda. Washington, District of Columbia | Who can sue the FDA? Answering Justice Alito’s question from the mifepristone arguments - 8 months ago Supreme Court mifepristone arguments focus on physicians’ right to sue, not FDA judgment - 8 months ago Supreme Court slates abortion pill case for March - 10 months ago Supreme Court will decide abortion pill access - 12 months ago | |
8 | Marissa Plescia MedCity News Reporter at MedCity News. | MedCity FemFwd: The Supreme Court’s Decision on Mifepristone - 5 months ago | |
9 | Katie Adams MedCity News Editor. Exeter, New Hampshire | ||
10 | Clare Wilson New Scientist Science news source. Worldwide |